Diffusion Tractography Biomarker for Epilepsy Severity in Children With Drug-Resistant Epilepsy
Jeong-Won Jeong1,2,3,4, Min-Hee Lee1,2, Hiroshi Uda1
1Department of Pediatrics, Wayne State University, Detroit, Michigan, USA.
Annals of Clinical and Translational Neurology
|October 9, 2025
Summary
A novel deep learning model accurately predicts epilepsy severity in pediatric drug-resistant epilepsy (DRE) patients. This tool aids in identifying neurocognitive impairments, enabling timely interventions for better outcomes.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Imaging
Background:
- Pediatric drug-resistant epilepsy (DRE) often co-occurs with neurocognitive impairments.
- Accurate assessment of epilepsy severity is crucial for predicting these impairments.
Purpose of the Study:
- To develop a deep learning model using diffusion-weighted imaging (DWI) tractography to predict epilepsy severity.
- To evaluate the model's ability to screen for neurocognitive impairments in pediatric DRE.
Main Methods:
- Constructed an epilepsy severity network (ESN) correlated with clinical GASE scores in DRE children.
- Utilized a dilated deep convolutional neural network with a relational network (dilated DCNN+RN) to generate a predicted GASE score biomarker.
- Validated the model on separate development and independent test sets, including a random score learning experiment to assess overfitting.
Main Results:
- The dilated DCNN+RN model achieved high correlation with clinical GASE scores (r=0.92 development, r=0.83 test).
- The model demonstrated minimal overfitting, outperforming state-of-the-art methods.
- Predicted GASE scores showed superior model fit and discriminatory ability compared to clinical GASE scores.
Conclusions:
- The developed deep learning biomarker shows significant potential for early identification of neurocognitive impairment risk in pediatric DRE.
- This tool can facilitate timely, personalized interventions to mitigate long-term effects of DRE.
